FDA advisors recommend AstraZeneca antibody to protect babies from RSV
-
In this articleSAN-FRAZN-GBFollow your favorite stocksCREATE FREE
ACCOUNTNarisara Nami | Moment | Getty ImagesA panel of independent advisors
to the Food a...
9 hours ago
From start 2010 to end 2017:
ReplyDeleteOpportunity cost in inflation: 18.9%
Opportunity cost with being invested in STI ETF (dividends re-invested): 42%
For those who believe in global diversification;
opportunity cost with being invested in ACWI ETF: 92% (in USD, slightly lesser in SGD) excluding dividends.
Opportunity cost for being able to sleep well at night: Priceless! ;)
PS: Portfolio value had some roller coaster rides if you were fully invested between 2010 & 2017. Especially STI ETF!